The oral antiviral from Merch and Ridgeback Biotherapeutics can reduce the risk of death and hospitalization by as much as 50 percent, its makers say.
“We’ve lost 700,000 Americans now and fully 200,000 of those folks have died since vaccines have been available almost to everyone in this country, and every one of those deaths is unnecessary,” Dr. Jonathan Reiner, a professor of medicine and surgery at George Washington University, told CNN
. “So even though the news is great for this antiviral agent, really the message that people need to receive is ‘get vaccinated.’ No one needs to die from this virus.”Here’s some other COVID-related news to close out the weekend:million people this weekend.
deaths reported on a seven-day average worldwide were recorded in the U.S., Russia, Brazil, Mexico, and India. [’s 47th season premiered last night to all-time low ratings in certain demos. Anyway, the cast and host Owen Wilson did a sketch making fun ofFully vaccinated Americans continues to stall at the just-over-half-of-us mark, with 55.9 percent of people in the U.S. having gotten all their shots.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
New COVID-19 pills may keep recently diagnosed patients out of hospital, company says
Les mer »
South Africa launches drive to vaccinate 500,000 in 2 daysSouth Africa has launched a new COVID-19 vaccination drive in an attempt to give doses to 500,000 people in two days.
Les mer »
American Airlines, Alaska, JetBlue Orders Workers to Get Covid-19 VaccinationsMore airlines are telling employees they’ll have to get Covid-19 vaccinations as carriers move to comply with new rules for companies that do business with the federal government.
Les mer »
Virus surge hits New England despite high vaccination ratesDespite having some of the highest vaccination rates in the U.S., the six New England states are still grappling with a surge of cases due to the delta variant. In some areas, hospitalizations are approaching the pandemic peak and ICUs are filling up.
Les mer »
Merck’s Covid-19 Drug Is a Boon for Wall Street and Main StreetMerck and partner Ridgeback Biotherapeutics released strong data for their new Covid-19 pill. WSJheard explains how this could be a boon on Main Street and Wall Street. WSJWhatsNow
Les mer »
Why a pill you take at home could change the direction of the pandemicMerck and Ridgeback Therapeutics Inc.'s promising oral antiviral could shift the direction of the pandemic by making it easier for people with COVID-19 to...
Les mer »